H

Hansoh Pharmaceutical Group Company Ltd
HKEX:3692

Watchlist Manager
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Watchlist
Price: 28.8 HKD -0.17% Market Closed
Market Cap: 171.3B HKD

EV/EBITDA
Enterprise Value to EBITDA

31.8
Current
18.4
Median
12.8
Industry
Higher than median
Higher than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
31.8
=
Enterprise Value
152.3B HKD
/
EBITDA
4.4B CNY

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
28.2
2-Years Forward
EV/EBITDA
26.7
3-Years Forward
EV/EBITDA
23.2